BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7031980)

  • 41. Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade.
    Dong H; Chen SX; Kini RM; Xu HX
    J Nat Prod; 1998 Nov; 61(11):1356-60. PubMed ID: 9834152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect in vitro of lanthanum, yttrium and cerium chlorides on the 1st phase of the thrombin-fibrinogen reaction].
    Ducastaing A; Monceyron C; Azanza JL; Creac'h P; Raymond J
    C R Seances Soc Biol Fil; 1973; 167(2):262-9. PubMed ID: 4802769
    [No Abstract]   [Full Text] [Related]  

  • 43. 2,3-diphosphoglycerate: a physiological inhibitor of platelet aggregation.
    Iatridis SG; Iatridis PG; Markidou SG; Ragatz BH
    Science; 1975 Jan; 187(4173):259-61. PubMed ID: 1111100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rate of fibrinopeptide B release modulates the rate of clot formation: a study with an acquired inhibitor to fibrinopeptide B release.
    Nawarawong W; Wyshock E; Meloni FJ; Weitz J; Schmaier AH
    Br J Haematol; 1991 Oct; 79(2):296-301. PubMed ID: 1958489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new thrombin-like enzyme, flavoviridiobin from the venom of Trimeresurus flavoviridis (habu).
    Tatematsu R; Komori Y; Nikai T
    J Nat Toxins; 2000 Nov; 9(4):327-39. PubMed ID: 11126511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of ascorbate and histidine in fibrinogen protection against changes following exposure to a sterilizing dose of gamma-irradiation.
    Zbikowska HM; Nowak P; Wachowicz B
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):669-76. PubMed ID: 17890955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a thrombin-like serine protease, Kangshuanmei, isolated from the venom of a Chinese snake, Agkistrodon halys brevicaudus stejneger.
    Zhang S; Ma B; Sakai J; Shiono H; Matsui T; Sugie I; Okada T
    J Nat Toxins; 2001 Aug; 10(3):221-38. PubMed ID: 11491462
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain.
    Francis CW; Bunce LA; Sporn LA
    Blood Cells; 1993; 19(2):291-306; discussion 306-7. PubMed ID: 8312565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on a procoagulant fraction of southern copperhead snake venom: the preferential release of fibrinopeptide B.
    Herzig RH; Ratnoff OD; Shainoff JR
    J Lab Clin Med; 1970 Sep; 76(3):451-65. PubMed ID: 5458334
    [No Abstract]   [Full Text] [Related]  

  • 50. Anticoagulants produced by thrombin from fibrin, the effect on blood coagulation, some physical characteristics.
    Muirhead CR; Triantaphyllopoulos DC
    Thromb Diath Haemorrh; 1971 Oct; 26(2):211-23. PubMed ID: 5316291
    [No Abstract]   [Full Text] [Related]  

  • 51. Full and partial deuterium solvent isotope effect studies of alpha-thrombin-catalyzed reactions of natural substrates.
    Zhang D; Kovach IM
    J Am Chem Soc; 2005 Mar; 127(11):3760-6. PubMed ID: 15771510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitor of blood clotting derived from prothrombin.
    Marciniak E; Murano G; Seegers WH
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):161-6. PubMed ID: 6071101
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of 2,3-diphosphoglycerate on oxygen consumption burst in thrombin-stimulated platelets.
    Del Principe D; Menichelli A; Damiano AM; Coppola L; Bastianon V
    Clin Chim Acta; 1977 Mar; 75(2):325-9. PubMed ID: 844210
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Congenital dysfibrinogenemia.
    Rupp C; Beck EA
    Curr Probl Clin Biochem; 1984; 14():65-130. PubMed ID: 6150812
    [No Abstract]   [Full Text] [Related]  

  • 55. Amino acids and peptides XII: synthetic peptides related to the N-terminal portion of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting.
    Kawasaki K; Hirase K; Tsuji T; Miyano M; Iwamoto M
    Thromb Res; 1989 Dec; 56(6):757-62. PubMed ID: 2633403
    [No Abstract]   [Full Text] [Related]  

  • 56. Establishing the inhibitory effects of bradykinin on thrombin.
    Cleary DB; Ehringer WD; Maurer MC
    Arch Biochem Biophys; 2003 Feb; 410(1):96-106. PubMed ID: 12559981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rheological studies of creep and creep recovery of unligated fibrin clots: comparison of clots prepared with thrombin and ancrod.
    Bale MD; Müller MF; Ferry JD
    Biopolymers; 1985 Mar; 24(3):461-82. PubMed ID: 3986291
    [No Abstract]   [Full Text] [Related]  

  • 58. Formation of anticoagulants by digesting fibrin with thrombin.
    Triantaphyllopoulos DC; Muirhead CR
    Thromb Diath Haemorrh; 1968 Jul; 19(3):397-402. PubMed ID: 5304346
    [No Abstract]   [Full Text] [Related]  

  • 59. Bovine fibrinogen modified with 3H-acetic anhydride (3H-AcOAc).
    Wegrzynowicz Z; Kloczewiak M; Kopec M
    J Lab Clin Med; 1975 Aug; 86(2):360-8. PubMed ID: 239078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclic amides of N alpha-arylsulfonylaminoacylated 4-amidinophenylalanine--tight binding inhibitors of thrombin.
    Stürzebecher J; Markwardt F; Voigt B; Wagner G; Walsmann P
    Thromb Res; 1983 Mar; 29(6):635-42. PubMed ID: 6857602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.